search
Back to results

Manging Post Spinal Hypotension During Elective Cesarean Section (EpiEph)

Primary Purpose

Hypotension

Status
Completed
Phase
Phase 4
Locations
Tunisia
Study Type
Interventional
Intervention
Adrenaline
Ephedrine
Sponsored by
Ben marzouk Sofiene
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypotension focused on measuring Epinephrine, Ephedrine, cesarean section, spinal anesthesia

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • ASA II
  • BMI>18 and <35 Kg/m2
  • full term parturients with singleton pregnancy
  • scheduled of elective cesarean section under spinal anesthesia

Non-inclusion criteria:

  • Patient refusal.
  • ASA > II
  • Preexisting or pregnancy-induced hypertension
  • The use of cardiac medication or medication for BP control.
  • Cardiovascular or cerebrovascular disease.
  • Multiple pregnancy.
  • Suspicion of abnormal placentation.
  • Known fetal abnormalities or fetal distress.
  • CS under general anesthesia.
  • Active labor.
  • Emergency.
  • Allergy to any of the medications used in the study.

Exclusion Criteria:

  • Hemodynamic instability that is not in relationship with SA (occurrence of a surgical per-operative complication e.g. bleeding by placental insertion abnormality or a uterine atony).
  • An abnormal extension of the anesthetic block defined as a sensory block level > D4.
  • SA failure.
  • The need to convert to general anesthesia.

Sites / Locations

  • Tunis maternity and neonatology center,

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Group Adrenaline: Group A

Group Ephedrine: Group E

Arm Description

All parturients received a prophylactic i.v bolus of Epinephrine 0.15µg/Kg at time of SA. In this group, rescue boluses of Epinephrine 0.15µg/Kg, will be given if maternal BP decreased more than 20% from the baseline value.

All parturients received a prophylactic i.v bolus of Ephedrine 0.1mg/Kg at time of SA. In this group, rescue boluses of Ephedrine 0.1mg/Kg, will be given if maternal BP decreased more than 20% from the baseline value.E

Outcomes

Primary Outcome Measures

delta SBP (D)
difference between baseline and the lowest systolic blood pressure.
delta MBP (D)
difference between baseline and the lowest mean blood pressure.

Secondary Outcome Measures

delta SBP (S)
difference between baseline and the lowest systolic blood pressure.
delta MBP (S)
difference between baseline and the lowest mean blood pressure.
time to onset of first post spinal hypotension episode
first episode of hypotension after spinal anesthesia induction
Incidence of post spinal hypotension
a decrease of SBP >20% of baseline
Vasopressor consumption
cumulative dose of vasopressor consumption
Vasopressor consumption
cumulative dose of vasopressor consumption
number of rescue boluses
number of rescue boluses before and after delivery
incidence of hypertension
a rise of SBP >20% of baseline
tachycardia
heart rate>140 beats/min
incidence of arrythmia
incidence of arrhythmic events
incidence of bradycardia
heart rate (HR) < 50 beats/min
use of atropine
cumulative dose, if needed
incidence of nausea and vomiting
Measure will be done according to a simple scale: 0= no nausea and vomiting; 1= nausea or vomiting
foetal gas analysis: pH, Lactates, HCO3-, BE
fetal cord blood analysis will be done immediately after delivery
APGAR score
range from 0 to 10,incorporates five elements: respiratory effort, heart rate, reflex irritability, muscle tone, and color A score of 0 to 3 indicates a severely depressed neonate, whereas a score of 7 to 10 is considered normal.

Full Information

First Posted
October 10, 2018
Last Updated
March 11, 2019
Sponsor
Ben marzouk Sofiene
search

1. Study Identification

Unique Protocol Identification Number
NCT03704909
Brief Title
Manging Post Spinal Hypotension During Elective Cesarean Section
Acronym
EpiEph
Official Title
Managing Post Spinal Hypotension During Elective Cesarean Section: Epinephrine Versus Ephedrine, a Randomized Double-blinded Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
September 1, 2018 (Actual)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ben marzouk Sofiene

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Spinal anesthesia is the gold standard technique for elective cesarean section. It helps to avoid risks regarding airway management and provides effective neuraxial postoperative analgesia, enabling quicker maternal recovery. Cesarean section normally require an anesthetic block at T4 level. So that maternal hypotension is reported to occur in up to 80%. This can result in significant morbidity for both the mother and fetus.The purpose of this study is to determine if epinephrine is as effective and safe compared to ephedrine for maintaining arterial blood pressure during elective cesarean section under spinal anesthesia. All participants will receive spinal anesthesia with a local anesthetic and sufentanil. This study plans to enroll 140 healthy pregnant women. Patients will be randomly assigned according to a computer generated system to be in one of two groups.
Detailed Description
Its a prospective double-blinded controlled trial. All participants gave a written informed consent. One hundred and twenty healthy women, ASA II, with singleton pregnancies at term scheduled for elective cesarean section under spinal anesthesia are targeted for the study. They are randomized to receive either epinephrine or ephedrine. Upon arrival in the operating room, parturient was placed in the supine position with 15° left lateral tilt with routine monitoring (HR, non-invasive BP, pulse oximetry, electrocardiography). Baseline BP and HR were computed as the mean of three consecutive BP and HR readings respectively at 1-minute intervals. Study participants will receive a standard spinal anesthetic consisting of 0.5% hyperbaric bupivacaine (2 mL) plus sufentanil (5 µg) at L3-4 vertebral interspace. Group A (for adrenaline group): received a prophylactic intravenous (i.v) bolus of Epinephrine 0.15µg/Kg at time of SA. In this group, rescue boluses of Epinephrine 0.15µg/Kg, were given if maternal BP decreased more than 20% from the baseline value. Group E (for ephedrine group): received a prophylactic i.v bolus of Ephedrine 0.1mg/Kg at time of SA. In this group, rescue boluses of Ephedrine 0.1mg/Kg, were given if maternal BP decreased more than 20% from the baseline value. Once the spinal injection was performed a rapid intravenous (i.v.) coload with 15mL/Kg of isotonic saline solution was started through a 16 G i.v. cannula (by turning the i.v. infusion to maximum and using a pressure bag inflated to 150 mmHg). A prophylactic bolus of vasopressor was administered at the end of spinal injection. After performing anesthesia, the parturient was immediately replaced in the supine position with a 15° left lateral table tilt until delivery of the infant. Prior to surgical incision, the spinal sensory level will be tested to the bilateral T6-T4 dermatomal level. Sensory block level was checked by cold-hot test and the Modified Bromage Scale was used for the assessment of motor block. The surgery was allowed when the sensory block level reached D4. Both the patient and the researcher's assistant (who will collect data) will be blinded as to the administered Epinephrine or Ephedrine bolus. Supplemental oxygen will be given only when the pulse oximeter reading decreased below 95%. After delivery, 5 IU of oxytocin diluted in 20 ml of isotonic saline solution were slowly injected over 1 minute. Then an i.v infusion was given (10 IU/500ml of isotonic saline solution at a flow rate of 28 drops/min). Heart rate (beats/min), systolic, mean and diastolic blood pressure (mmHg) will be recorded every 1 min after spinal injection until the end of surgery. The incidence of hypotension (defined as a reduction in SBP of >20% from baseline determined just before the administration of spinal anesthesia) will be recorded. Reactive hypertension (defined as a rise of SBP >20% of baseline) will also be recorded. Bradycardia (defined as HR <50 beats/min) will be recorded. Tachycardia (defined as a HR >140 beats/min) will also be recorded. Umbilical blood samples will be obtained by clamping it on both sides and a gas analysis will be performed to determine fetal pH, HCO3-, base excess and lactates. Furthermore, Apgar scores at 1 and 5 minutes after delivery will be recorded by the attending pediatrician, who will be unaware of the vasopressor used. The study will end when cesarean section is completed and the patient is transferred to the post-operative care unit.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension
Keywords
Epinephrine, Ephedrine, cesarean section, spinal anesthesia

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
143 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group Adrenaline: Group A
Arm Type
Active Comparator
Arm Description
All parturients received a prophylactic i.v bolus of Epinephrine 0.15µg/Kg at time of SA. In this group, rescue boluses of Epinephrine 0.15µg/Kg, will be given if maternal BP decreased more than 20% from the baseline value.
Arm Title
Group Ephedrine: Group E
Arm Type
Active Comparator
Arm Description
All parturients received a prophylactic i.v bolus of Ephedrine 0.1mg/Kg at time of SA. In this group, rescue boluses of Ephedrine 0.1mg/Kg, will be given if maternal BP decreased more than 20% from the baseline value.E
Intervention Type
Drug
Intervention Name(s)
Adrenaline
Other Intervention Name(s)
epinehrine
Intervention Description
i.v bolus of adrenaline 0.15µg/Kg rescue boluses of adrenaline 0.15µg/Kg
Intervention Type
Drug
Intervention Name(s)
Ephedrine
Intervention Description
i.v bolus of Ephedrine 0.1mg/Kg rescue boluses of Ephedrine 0.1mg/Kg
Primary Outcome Measure Information:
Title
delta SBP (D)
Description
difference between baseline and the lowest systolic blood pressure.
Time Frame
at the end of intrathecal injection until delivery
Title
delta MBP (D)
Description
difference between baseline and the lowest mean blood pressure.
Time Frame
at the end of intrathecal injection until delivery
Secondary Outcome Measure Information:
Title
delta SBP (S)
Description
difference between baseline and the lowest systolic blood pressure.
Time Frame
at the end of intrathecal injection until the end of surgery
Title
delta MBP (S)
Description
difference between baseline and the lowest mean blood pressure.
Time Frame
at the end of intrathecal injection until the end of surgery
Title
time to onset of first post spinal hypotension episode
Description
first episode of hypotension after spinal anesthesia induction
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
Incidence of post spinal hypotension
Description
a decrease of SBP >20% of baseline
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
Vasopressor consumption
Description
cumulative dose of vasopressor consumption
Time Frame
from the end of intrathecal injection until delivery.
Title
Vasopressor consumption
Description
cumulative dose of vasopressor consumption
Time Frame
from the end of intrathecal injection until the end of surgery.
Title
number of rescue boluses
Description
number of rescue boluses before and after delivery
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
incidence of hypertension
Description
a rise of SBP >20% of baseline
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
tachycardia
Description
heart rate>140 beats/min
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
incidence of arrythmia
Description
incidence of arrhythmic events
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
incidence of bradycardia
Description
heart rate (HR) < 50 beats/min
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
use of atropine
Description
cumulative dose, if needed
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
incidence of nausea and vomiting
Description
Measure will be done according to a simple scale: 0= no nausea and vomiting; 1= nausea or vomiting
Time Frame
At time of surgery (right after spinal anesthesia until end of surgery)
Title
foetal gas analysis: pH, Lactates, HCO3-, BE
Description
fetal cord blood analysis will be done immediately after delivery
Time Frame
At time of birth
Title
APGAR score
Description
range from 0 to 10,incorporates five elements: respiratory effort, heart rate, reflex irritability, muscle tone, and color A score of 0 to 3 indicates a severely depressed neonate, whereas a score of 7 to 10 is considered normal.
Time Frame
at 1 and 5 minutes after birth

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ASA II BMI>18 and <35 Kg/m2 full term parturients with singleton pregnancy scheduled of elective cesarean section under spinal anesthesia Non-inclusion criteria: Patient refusal. ASA > II Preexisting or pregnancy-induced hypertension The use of cardiac medication or medication for BP control. Cardiovascular or cerebrovascular disease. Multiple pregnancy. Suspicion of abnormal placentation. Known fetal abnormalities or fetal distress. CS under general anesthesia. Active labor. Emergency. Allergy to any of the medications used in the study. Exclusion Criteria: Hemodynamic instability that is not in relationship with SA (occurrence of a surgical per-operative complication e.g. bleeding by placental insertion abnormality or a uterine atony). An abnormal extension of the anesthetic block defined as a sensory block level > D4. SA failure. The need to convert to general anesthesia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
HAYEN MAGHREBIG, PROFESSOR
Organizational Affiliation
UNIVERSITY OF TUNIS EL MANAR
Official's Role
Study Chair
Facility Information:
Facility Name
Tunis maternity and neonatology center,
City
Tunis
ZIP/Postal Code
1007
Country
Tunisia

12. IPD Sharing Statement

Learn more about this trial

Manging Post Spinal Hypotension During Elective Cesarean Section

We'll reach out to this number within 24 hrs